Previous diagnosis of diffuse large B-cell lymphoma with/without a discordant component of indolent B-cell lymphoma, or previous diagnosis of diffuse large B-cell lymphoma transformed from indolent B-cell lymphoma.
First-line treatment for diffuse large B-cell lymphoma.
Histologically documented relapse of indolent B-cell lymphoma, diagnosed between 2010 and 2020.
Availability of the histological report of the relapse.
Availability of clinical and laboratory data related to both the initial diagnosis and relapse.
Availability of follow-up data.
Consent to participate in the study and signing of the specific informed consent form (for living and/or contactable patients).
You may not be if
\- None
Clareo Health | Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma
